Viveve Medical Company Profile (OTCMKTS:PLCSD)

About Viveve Medical (OTCMKTS:PLCSD)

Viveve Medical logoViveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • CUSIP: N/A
  • Web: N/A
  • Trailing P/E Ratio:
  • P/E Growth:
  • Dividend Yield: 1.0%

Frequently Asked Questions for Viveve Medical (OTCMKTS:PLCSD)

What is Viveve Medical's stock symbol?

Viveve Medical trades on the OTCMKTS under the ticker symbol "PLCSD."

Where is Viveve Medical's stock going? Where will Viveve Medical's stock price be in 2017?

1 analysts have issued 1-year price objectives for Viveve Medical's shares. Their forecasts range from $11.00 to $11.00. On average, they expect Viveve Medical's share price to reach $11.00 in the next year. View Analyst Ratings for Viveve Medical.

Who are some of Viveve Medical's key competitors?

How do I buy Viveve Medical stock?

Shares of Viveve Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Viveve Medical stock cost?

One share of Viveve Medical stock can currently be purchased for approximately $0.81.

Analyst Ratings

Consensus Ratings for Viveve Medical (OTCMKTS:PLCSD) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.00

Analysts' Ratings History for Viveve Medical (OTCMKTS:PLCSD)
DateFirmActionRatingPrice TargetDetails
6/21/2016Maxim GroupLower Price TargetBuy$16.00 -> $11.00View Rating Details
(Data available from 5/24/2015 forward)


Earnings History for Viveve Medical (OTCMKTS:PLCSD)
No earnings announcements for this company have been tracked by


Earnings Estimates for Viveve Medical (OTCMKTS:PLCSD)

No earnings estimates for this company have been tracked by


Dividend History for Viveve Medical (OTCMKTS:PLCSD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Viveve Medical (OTCMKTS:PLCSD)
Insider Trades by Quarter for Viveve Medical (OTCMKTS:PLCSD)
Insider Trades by Quarter for Viveve Medical (OTCMKTS:PLCSD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/23/20145Am Partners Ii, LlcMajor ShareholderBuy5,215,664$0.53$2,764,301.92View SEC Filing  
9/23/2014Daniel JanneyDirectorBuy1,895,788$0.53$1,004,767.64View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Viveve Medical (OTCMKTS:PLCSD)
Latest Headlines for Viveve Medical (OTCMKTS:PLCSD)
No headlines for this company have been tracked by



Viveve Medical (PLCSD) Chart for Wednesday, May, 24, 2017

This page was last updated on 5/24/2017 by Staff